

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.02582805 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.53149526 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.53149526 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.78304394 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.78304394 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.69416745 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.48300682 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 5.29534045 |
| 9 | negative T cell selection (GO:0043383) | 5.13664794 |
| 10 | negative thymic T cell selection (GO:0045060) | 5.08162671 |
| 11 | response to interleukin-15 (GO:0070672) | 5.05753388 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.00842411 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.95371904 |
| 14 | leukocyte aggregation (GO:0070486) | 4.94935869 |
| 15 | positive thymic T cell selection (GO:0045059) | 4.93178590 |
| 16 | detection of other organism (GO:0098543) | 4.75976238 |
| 17 | response to peptidoglycan (GO:0032494) | 4.71573866 |
| 18 | detection of bacterium (GO:0016045) | 4.63547350 |
| 19 | B cell receptor signaling pathway (GO:0050853) | 4.54803473 |
| 20 | cellular response to interleukin-15 (GO:0071350) | 4.49122272 |
| 21 | thymic T cell selection (GO:0045061) | 4.47451438 |
| 22 | T cell selection (GO:0045058) | 4.45327513 |
| 23 | positive T cell selection (GO:0043368) | 4.43873711 |
| 24 | tolerance induction (GO:0002507) | 4.37631801 |
| 25 | T cell migration (GO:0072678) | 4.34340667 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 4.32893535 |
| 27 | regulation of B cell differentiation (GO:0045577) | 4.30777911 |
| 28 | interferon-gamma production (GO:0032609) | 4.09897978 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.03644186 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.98040330 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.90671567 |
| 32 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.75687198 |
| 33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.73128024 |
| 34 | activated T cell proliferation (GO:0050798) | 3.70647537 |
| 35 | T cell receptor signaling pathway (GO:0050852) | 3.67139084 |
| 36 | response to host immune response (GO:0052572) | 3.67099593 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.67099593 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 3.60388040 |
| 39 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.58169550 |
| 40 | cellular extravasation (GO:0045123) | 3.58167831 |
| 41 | detection of molecule of bacterial origin (GO:0032490) | 3.56687713 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.54295599 |
| 43 | T cell homeostasis (GO:0043029) | 3.49494586 |
| 44 | T cell costimulation (GO:0031295) | 3.49327542 |
| 45 | detection of biotic stimulus (GO:0009595) | 3.45829653 |
| 46 | mast cell activation (GO:0045576) | 3.45210269 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.43835844 |
| 48 | response to host (GO:0075136) | 3.43835844 |
| 49 | response to host defenses (GO:0052200) | 3.43835844 |
| 50 | lymphocyte costimulation (GO:0031294) | 3.43016615 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.39812950 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.39812950 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 3.39812950 |
| 54 | positive regulation by symbiont of host defense response (GO:0052509) | 3.39812950 |
| 55 | modulation by symbiont of host defense response (GO:0052031) | 3.39812950 |
| 56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.39812950 |
| 57 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.39537569 |
| 58 | cellular response to type I interferon (GO:0071357) | 3.37464106 |
| 59 | type I interferon signaling pathway (GO:0060337) | 3.37464106 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.37234130 |
| 61 | positive regulation of interleukin-2 production (GO:0032743) | 3.37206938 |
| 62 | response to type I interferon (GO:0034340) | 3.35750513 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.35363935 |
| 64 | microglial cell activation (GO:0001774) | 3.35291029 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 3.34044346 |
| 66 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.33531727 |
| 67 | leukocyte cell-cell adhesion (GO:0007159) | 3.32000169 |
| 68 | mature B cell differentiation (GO:0002335) | 3.31945983 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.30942752 |
| 70 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.30929081 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.30284971 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.30259024 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 3.27731592 |
| 74 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27602888 |
| 75 | macrophage activation (GO:0042116) | 3.27456108 |
| 76 | lymphocyte homeostasis (GO:0002260) | 3.23940448 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.23661241 |
| 78 | natural killer cell differentiation (GO:0001779) | 3.23106334 |
| 79 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.21965914 |
| 80 | mast cell activation involved in immune response (GO:0002279) | 3.20800527 |
| 81 | mast cell degranulation (GO:0043303) | 3.20800527 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.18846313 |
| 83 | leukocyte degranulation (GO:0043299) | 3.17872854 |
| 84 | neutrophil mediated immunity (GO:0002446) | 3.17852587 |
| 85 | positive regulation of mast cell activation (GO:0033005) | 3.17750688 |
| 86 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17434615 |
| 87 | myeloid dendritic cell activation (GO:0001773) | 3.11882545 |
| 88 | regulation of mast cell activation (GO:0033003) | 3.10961391 |
| 89 | positive regulation of isotype switching (GO:0045830) | 3.10808756 |
| 90 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.10220150 |
| 91 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09760894 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.07795428 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 3.06617511 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 3.06046209 |
| 95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04629299 |
| 96 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04179808 |
| 97 | neutrophil activation (GO:0042119) | 3.03501302 |
| 98 | negative regulation of innate immune response (GO:0045824) | 3.01251601 |
| 99 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.00952902 |
| 100 | B cell mediated immunity (GO:0019724) | 3.00549038 |
| 101 | negative regulation of interleukin-6 production (GO:0032715) | 2.99909376 |
| 102 | regulation of regulatory T cell differentiation (GO:0045589) | 2.99885746 |
| 103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.98815409 |
| 104 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.98426469 |
| 105 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.97992095 |
| 106 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97807354 |
| 107 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97257775 |
| 108 | immunoglobulin mediated immune response (GO:0016064) | 2.96842504 |
| 109 | myeloid dendritic cell differentiation (GO:0043011) | 2.96110743 |
| 110 | T cell proliferation (GO:0042098) | 2.96017053 |
| 111 | natural killer cell activation (GO:0030101) | 2.95811423 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95174496 |
| 113 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94869812 |
| 114 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94869812 |
| 115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.93889059 |
| 116 | positive regulation of histone deacetylation (GO:0031065) | 2.93002493 |
| 117 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.92992376 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 2.92799960 |
| 119 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89940797 |
| 120 | B cell homeostasis (GO:0001782) | 2.89610145 |
| 121 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.89138537 |
| 122 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.89138537 |
| 123 | macrophage activation involved in immune response (GO:0002281) | 2.88772777 |
| 124 | response to protozoan (GO:0001562) | 2.88681378 |
| 125 | neutrophil activation involved in immune response (GO:0002283) | 2.88524825 |
| 126 | response to muramyl dipeptide (GO:0032495) | 2.88493048 |
| 127 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.88045540 |
| 128 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.87570651 |
| 129 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86528416 |
| 130 | granulocyte activation (GO:0036230) | 2.83406399 |
| 131 | positive regulation of tolerance induction (GO:0002645) | 2.82686340 |
| 132 | leukocyte homeostasis (GO:0001776) | 2.82633262 |
| 133 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81955277 |
| 134 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81613724 |
| 135 | regulation of response to interferon-gamma (GO:0060330) | 2.80259370 |
| 136 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.78987596 |
| 137 | germinal center formation (GO:0002467) | 2.78436456 |
| 138 | respiratory burst (GO:0045730) | 2.76414105 |
| 139 | defense response to protozoan (GO:0042832) | 2.75951248 |
| 140 | megakaryocyte development (GO:0035855) | 2.74777020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.23407138 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.05973151 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.27061284 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.09779159 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.65733783 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.47675640 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.42437870 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.30420764 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.19379453 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.19212974 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.08626134 |
| 12 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.02350941 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.89177628 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.85602802 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.84762209 |
| 16 | * MAF_26560356_Chip-Seq_TH1_Human | 2.83722283 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82766064 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.80785181 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80277562 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.74630396 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.65427938 |
| 22 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.63171359 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.62316666 |
| 24 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58560448 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56535607 |
| 26 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.55328278 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.54564899 |
| 28 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48655944 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.45211631 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41206402 |
| 31 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.35380087 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.24625334 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20012926 |
| 34 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.19552069 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 2.18052374 |
| 36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.18015547 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.15394789 |
| 38 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14091977 |
| 39 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12930340 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.09550004 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91996946 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.91509375 |
| 43 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89788794 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85745801 |
| 45 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.76563698 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70036961 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59006128 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.48588921 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47247304 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46248227 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.44913317 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44260360 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41128966 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37589464 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37449751 |
| 56 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.37182865 |
| 57 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36764445 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36405498 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35715256 |
| 60 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35656809 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33529334 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30455097 |
| 63 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29037885 |
| 64 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26404529 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24692739 |
| 66 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.23180492 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21341355 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18205819 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18071122 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13839116 |
| 71 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13799181 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13527010 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11247413 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10788585 |
| 75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09767493 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09112733 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08785470 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08500714 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07113703 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06677157 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06074135 |
| 82 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04671530 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02247398 |
| 84 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00562498 |
| 85 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.00460679 |
| 86 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99855132 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98761351 |
| 88 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98739346 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97816483 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97063893 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96691397 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93998325 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93122932 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91223343 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90477919 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90033199 |
| 97 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89543625 |
| 98 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89191949 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87705968 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86727872 |
| 101 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.85617899 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81554708 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80832795 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78043680 |
| 105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75025554 |
| 106 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74449420 |
| 107 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.74388658 |
| 108 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.73458008 |
| 109 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71358696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.80485062 |
| 2 | MP0003303_peritoneal_inflammation | 3.45244731 |
| 3 | MP0005671_abnormal_response_to | 3.39846134 |
| 4 | MP0000685_abnormal_immune_system | 3.36327655 |
| 5 | MP0001800_abnormal_humoral_immune | 3.34857704 |
| 6 | MP0001790_abnormal_immune_system | 3.30410598 |
| 7 | MP0005387_immune_system_phenotype | 3.30410598 |
| 8 | MP0003763_abnormal_thymus_physiology | 3.28292363 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.91034388 |
| 10 | MP0003436_decreased_susceptibility_to | 2.88416523 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.83895717 |
| 12 | MP0002723_abnormal_immune_serum | 2.79166975 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.78035807 |
| 14 | MP0001819_abnormal_immune_cell | 2.74876980 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.69017503 |
| 16 | MP0002398_abnormal_bone_marrow | 2.66933356 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.56736150 |
| 18 | MP0009785_altered_susceptibility_to | 2.54533647 |
| 19 | MP0004510_myositis | 2.49134754 |
| 20 | MP0005025_abnormal_response_to | 2.46202404 |
| 21 | MP0002419_abnormal_innate_immunity | 2.38197082 |
| 22 | MP0000716_abnormal_immune_system | 2.36694552 |
| 23 | MP0001873_stomach_inflammation | 2.23520827 |
| 24 | MP0002405_respiratory_system_inflammati | 2.23098230 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.22149273 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.18279546 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.15476183 |
| 28 | MP0002722_abnormal_immune_system | 2.13607992 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 2.12437695 |
| 30 | MP0006082_CNS_inflammation | 2.10948310 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 2.09250514 |
| 32 | MP0000703_abnormal_thymus_morphology | 2.07694182 |
| 33 | MP0009278_abnormal_bone_marrow | 2.05812885 |
| 34 | MP0010155_abnormal_intestine_physiology | 2.00195973 |
| 35 | MP0002429_abnormal_blood_cell | 1.94793584 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.91803326 |
| 37 | MP0003866_abnormal_defecation | 1.90500171 |
| 38 | MP0004947_skin_inflammation | 1.85200886 |
| 39 | MP0008260_abnormal_autophagy | 1.84142273 |
| 40 | MP0002006_tumorigenesis | 1.78468176 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.75567888 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.69149584 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.69149584 |
| 44 | MP0001853_heart_inflammation | 1.67355118 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.66151209 |
| 46 | MP0005310_abnormal_salivary_gland | 1.54910669 |
| 47 | MP0005451_abnormal_body_composition | 1.51949293 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.51439964 |
| 49 | MP0002933_joint_inflammation | 1.43347778 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.41886789 |
| 51 | MP0003724_increased_susceptibility_to | 1.40248993 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.35925795 |
| 53 | MP0004381_abnormal_hair_follicle | 1.35909138 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.34130829 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.28332168 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.26344356 |
| 57 | MP0008469_abnormal_protein_level | 1.17790009 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.17285686 |
| 59 | MP0004883_abnormal_blood_vessel | 1.14796890 |
| 60 | MP0003448_altered_tumor_morphology | 1.14567412 |
| 61 | MP0001851_eye_inflammation | 1.14101999 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.13889506 |
| 63 | MP0000858_altered_metastatic_potential | 1.10834913 |
| 64 | MP0000490_abnormal_crypts_of | 1.09227836 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.05947993 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.01766237 |
| 67 | MP0003690_abnormal_glial_cell | 1.01401759 |
| 68 | MP0002019_abnormal_tumor_incidence | 0.89927504 |
| 69 | MP0003075_altered_response_to | 0.89319100 |
| 70 | MP0005164_abnormal_response_to | 0.87922649 |
| 71 | MP0010307_abnormal_tumor_latency | 0.87593704 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 0.87445329 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.87090560 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.86710260 |
| 75 | MP0005166_decreased_susceptibility_to | 0.85177504 |
| 76 | MP0005390_skeleton_phenotype | 0.84223624 |
| 77 | MP0008004_abnormal_stomach_pH | 0.81651111 |
| 78 | MP0003045_fibrosis | 0.79420804 |
| 79 | MP0002009_preneoplasia | 0.78705549 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.77736329 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.75550562 |
| 82 | MP0001663_abnormal_digestive_system | 0.74927758 |
| 83 | MP0008874_decreased_physiological_sensi | 0.74468978 |
| 84 | MP0000343_altered_response_to | 0.71873550 |
| 85 | MP0004859_abnormal_synaptic_plasticity | 0.71133770 |
| 86 | MP0003828_pulmonary_edema | 0.69872650 |
| 87 | MP0009764_decreased_sensitivity_to | 0.69043699 |
| 88 | MP0000604_amyloidosis | 0.66994582 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 0.65430586 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.64791542 |
| 91 | MP0003091_abnormal_cell_migration | 0.62212582 |
| 92 | MP0008569_lethality_at_weaning | 0.59718712 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58211394 |
| 94 | MP0003787_abnormal_imprinting | 0.57884317 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.57800131 |
| 96 | MP0002928_abnormal_bile_duct | 0.56833173 |
| 97 | MP0004130_abnormal_muscle_cell | 0.56104291 |
| 98 | MP0002138_abnormal_hepatobiliary_system | 0.55496057 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.53667534 |
| 100 | MP0005023_abnormal_wound_healing | 0.53364893 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.52683583 |
| 102 | MP0000249_abnormal_blood_vessel | 0.52211435 |
| 103 | MP0009763_increased_sensitivity_to | 0.52078955 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.49953779 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.49028781 |
| 106 | MP0002132_abnormal_respiratory_system | 0.48906866 |
| 107 | MP0008873_increased_physiological_sensi | 0.48647072 |
| 108 | MP0000313_abnormal_cell_death | 0.47222217 |
| 109 | MP0000371_diluted_coat_color | 0.47176337 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.46043431 |
| 111 | MP0005621_abnormal_cell_physiology | 0.45587282 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.45524593 |
| 113 | MP0002083_premature_death | 0.45063083 |
| 114 | MP0009840_abnormal_foam_cell | 0.44933042 |
| 115 | MP0000609_abnormal_liver_physiology | 0.43756955 |
| 116 | MP0003795_abnormal_bone_structure | 0.43436453 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.42336925 |
| 118 | MP0003077_abnormal_cell_cycle | 0.39071006 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.38692940 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 0.38243689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.65718338 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.64810993 |
| 3 | Recurrent viral infections (HP:0004429) | 4.64610043 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.63841613 |
| 5 | T lymphocytopenia (HP:0005403) | 4.53073442 |
| 6 | IgM deficiency (HP:0002850) | 4.41088449 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 4.36869560 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.31590835 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.29010518 |
| 10 | Chronic otitis media (HP:0000389) | 4.27100706 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.11636244 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.03695987 |
| 13 | Myositis (HP:0100614) | 3.94084621 |
| 14 | Cellulitis (HP:0100658) | 3.82247026 |
| 15 | Inflammation of the large intestine (HP:0002037) | 3.81016970 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.78724154 |
| 17 | Meningitis (HP:0001287) | 3.75646542 |
| 18 | Agammaglobulinemia (HP:0004432) | 3.74999819 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.73659116 |
| 20 | Nasal polyposis (HP:0100582) | 3.67205400 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.66102105 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.66102105 |
| 23 | Abnormality of T cells (HP:0002843) | 3.63647210 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.53221119 |
| 25 | Colitis (HP:0002583) | 3.48897708 |
| 26 | Papilloma (HP:0012740) | 3.46785881 |
| 27 | Verrucae (HP:0200043) | 3.46785881 |
| 28 | Thyroiditis (HP:0100646) | 3.33061200 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.29796523 |
| 30 | B lymphocytopenia (HP:0010976) | 3.29796523 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.28537769 |
| 32 | Urticaria (HP:0001025) | 3.25242724 |
| 33 | Pustule (HP:0200039) | 3.24032643 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 3.23079190 |
| 35 | Recurrent skin infections (HP:0001581) | 3.22211316 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.19772013 |
| 37 | Stomatitis (HP:0010280) | 3.15917620 |
| 38 | Keratoconjunctivitis (HP:0001096) | 3.14276817 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.10274819 |
| 40 | Obstructive lung disease (HP:0006536) | 3.10274819 |
| 41 | Vasculitis (HP:0002633) | 3.05013100 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 3.02853673 |
| 43 | Severe combined immunodeficiency (HP:0004430) | 2.99862122 |
| 44 | Increased IgE level (HP:0003212) | 2.96755071 |
| 45 | Lymphopenia (HP:0001888) | 2.88980550 |
| 46 | Episodic fever (HP:0001954) | 2.85300050 |
| 47 | Hypochromic anemia (HP:0001931) | 2.83749253 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.83558479 |
| 49 | Combined immunodeficiency (HP:0005387) | 2.83177251 |
| 50 | Hypochromic microcytic anemia (HP:0004840) | 2.81983011 |
| 51 | Eosinophilia (HP:0001880) | 2.78526219 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.78491749 |
| 53 | Abnormality of macrophages (HP:0004311) | 2.75760592 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.74876591 |
| 55 | Optic neuritis (HP:0100653) | 2.70842245 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.70842245 |
| 57 | Orchitis (HP:0100796) | 2.68361286 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67516821 |
| 59 | Leukocytosis (HP:0001974) | 2.67212276 |
| 60 | Thrombocytosis (HP:0001894) | 2.66672107 |
| 61 | Chronic sinusitis (HP:0011109) | 2.59232673 |
| 62 | Increased IgM level (HP:0003496) | 2.58229756 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.56768478 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.56442351 |
| 65 | Chest pain (HP:0100749) | 2.56213995 |
| 66 | Gastrointestinal stroma tumor (HP:0100723) | 2.52065867 |
| 67 | Encephalitis (HP:0002383) | 2.48808759 |
| 68 | Anorexia (HP:0002039) | 2.48405299 |
| 69 | Amyloidosis (HP:0011034) | 2.48253739 |
| 70 | IgG deficiency (HP:0004315) | 2.47612308 |
| 71 | Arterial thrombosis (HP:0004420) | 2.46417804 |
| 72 | Increased density of long bones (HP:0006392) | 2.43535694 |
| 73 | Granulocytopenia (HP:0001913) | 2.42443589 |
| 74 | Chronic diarrhea (HP:0002028) | 2.41225739 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.36741125 |
| 76 | Periodontitis (HP:0000704) | 2.33420566 |
| 77 | Hemoptysis (HP:0002105) | 2.33035212 |
| 78 | Epistaxis (HP:0000421) | 2.31256525 |
| 79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.31128197 |
| 80 | Osteomyelitis (HP:0002754) | 2.30851958 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.29530175 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.26919016 |
| 83 | Abnormal platelet function (HP:0011869) | 2.26919016 |
| 84 | Petechiae (HP:0000967) | 2.25702181 |
| 85 | Gingivitis (HP:0000230) | 2.24726203 |
| 86 | Emphysema (HP:0002097) | 2.21915717 |
| 87 | Slow saccadic eye movements (HP:0000514) | 2.21694484 |
| 88 | Bronchitis (HP:0012387) | 2.19864469 |
| 89 | Abnormality of the pleura (HP:0002103) | 2.19692404 |
| 90 | Peritonitis (HP:0002586) | 2.19652780 |
| 91 | IgA deficiency (HP:0002720) | 2.16061816 |
| 92 | Loss of speech (HP:0002371) | 2.15433337 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14851781 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14851781 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14851781 |
| 96 | Increased serum ferritin (HP:0003281) | 2.14710124 |
| 97 | Microcytic anemia (HP:0001935) | 2.13569622 |
| 98 | Gangrene (HP:0100758) | 2.13251758 |
| 99 | Sepsis (HP:0100806) | 2.12951985 |
| 100 | Fatigue (HP:0012378) | 2.10449114 |
| 101 | Autoimmune hemolytic anemia (HP:0001890) | 2.09117448 |
| 102 | Viral hepatitis (HP:0006562) | 2.08572176 |
| 103 | Gingival bleeding (HP:0000225) | 2.06254432 |
| 104 | Purpura (HP:0000979) | 2.06132006 |
| 105 | Abnormal platelet volume (HP:0011876) | 2.04619122 |
| 106 | Lymphoma (HP:0002665) | 2.03884708 |
| 107 | Hepatosplenomegaly (HP:0001433) | 2.02156602 |
| 108 | Glomerulopathy (HP:0100820) | 2.01882857 |
| 109 | Premature loss of primary teeth (HP:0006323) | 2.01521123 |
| 110 | Abnormality of the peritoneum (HP:0002585) | 2.00550933 |
| 111 | Hematochezia (HP:0002573) | 2.00367084 |
| 112 | Skin ulcer (HP:0200042) | 1.97685545 |
| 113 | Abnormality of the endocardium (HP:0004306) | 1.96840658 |
| 114 | Dysostosis multiplex (HP:0000943) | 1.94151913 |
| 115 | Restrictive lung disease (HP:0002091) | 1.93340779 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.92900604 |
| 117 | Increased cerebral lipofuscin (HP:0011813) | 1.91834434 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.91301361 |
| 119 | Basal cell carcinoma (HP:0002671) | 1.90462960 |
| 120 | Joint swelling (HP:0001386) | 1.89620915 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88184841 |
| 122 | Cheilitis (HP:0100825) | 1.85902728 |
| 123 | Acne (HP:0001061) | 1.85744743 |
| 124 | Pulmonary embolism (HP:0002204) | 1.78953289 |
| 125 | Recurrent otitis media (HP:0000403) | 1.78866395 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.78582775 |
| 127 | Hypoplasia of the thymus (HP:0000778) | 1.77056458 |
| 128 | Papilledema (HP:0001085) | 1.76984833 |
| 129 | Gastrointestinal infarctions (HP:0005244) | 1.71790382 |
| 130 | Arthralgia (HP:0002829) | 1.71194622 |
| 131 | Hyperacusis (HP:0010780) | 1.71013538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.77145677 |
| 2 | PRPF4B | 3.18717789 |
| 3 | TXK | 3.00296952 |
| 4 | EEF2K | 2.83923687 |
| 5 | GRK6 | 2.71041370 |
| 6 | JAK3 | 2.54028569 |
| 7 | TYK2 | 2.43255285 |
| 8 | MAP3K10 | 2.42900001 |
| 9 | ZAP70 | 2.30429940 |
| 10 | STK10 | 2.27489707 |
| 11 | SIK2 | 2.10212794 |
| 12 | ITK | 2.06239704 |
| 13 | RIPK4 | 2.05840520 |
| 14 | FES | 1.99399401 |
| 15 | SYK | 1.95846105 |
| 16 | BTK | 1.95743641 |
| 17 | JAK1 | 1.93804470 |
| 18 | MAP3K13 | 1.92423760 |
| 19 | TRIB3 | 1.89269721 |
| 20 | MAP3K14 | 1.87858175 |
| 21 | PKN2 | 1.86982670 |
| 22 | BLK | 1.80653606 |
| 23 | CSF1R | 1.75980587 |
| 24 | HCK | 1.69360217 |
| 25 | MAP3K3 | 1.59016724 |
| 26 | EPHB1 | 1.56410532 |
| 27 | IKBKE | 1.55384390 |
| 28 | TBK1 | 1.54881438 |
| 29 | IRAK4 | 1.53043260 |
| 30 | LCK | 1.52121118 |
| 31 | CSK | 1.51989626 |
| 32 | MAP3K11 | 1.50336452 |
| 33 | KIT | 1.47813892 |
| 34 | ERN1 | 1.44832165 |
| 35 | TGFBR2 | 1.41291523 |
| 36 | FGFR4 | 1.38129411 |
| 37 | FGFR3 | 1.34675867 |
| 38 | CLK1 | 1.34113750 |
| 39 | TEC | 1.32611190 |
| 40 | LRRK2 | 1.32420963 |
| 41 | CDK12 | 1.30620035 |
| 42 | MAP3K1 | 1.22531829 |
| 43 | TNK2 | 1.17069588 |
| 44 | MARK3 | 1.13074938 |
| 45 | PRKCH | 1.10994593 |
| 46 | MAP2K3 | 1.07391188 |
| 47 | ALK | 1.04947879 |
| 48 | JAK2 | 1.04632199 |
| 49 | MAP3K7 | 1.02130549 |
| 50 | IKBKB | 0.99753056 |
| 51 | SMG1 | 0.99412696 |
| 52 | PIM1 | 0.97924444 |
| 53 | TAOK2 | 0.96252275 |
| 54 | SIK3 | 0.93983792 |
| 55 | LYN | 0.93958845 |
| 56 | YES1 | 0.90697178 |
| 57 | IRAK1 | 0.90496576 |
| 58 | PDK1 | 0.88460941 |
| 59 | TAOK1 | 0.88191296 |
| 60 | MATK | 0.85428660 |
| 61 | IRAK2 | 0.84888918 |
| 62 | BMPR2 | 0.83734726 |
| 63 | SIK1 | 0.83455013 |
| 64 | PRKCQ | 0.83183915 |
| 65 | NLK | 0.82259775 |
| 66 | CDC42BPA | 0.80972499 |
| 67 | IRAK3 | 0.75450229 |
| 68 | PTK6 | 0.72919753 |
| 69 | TTN | 0.69368939 |
| 70 | CDK4 | 0.68512031 |
| 71 | CAMK1G | 0.67659383 |
| 72 | CHUK | 0.64180675 |
| 73 | MARK2 | 0.62243889 |
| 74 | RPS6KA4 | 0.62104013 |
| 75 | HIPK2 | 0.61656846 |
| 76 | SGK3 | 0.59331550 |
| 77 | CAMK1D | 0.59104442 |
| 78 | TAOK3 | 0.57770990 |
| 79 | MAP3K6 | 0.54752725 |
| 80 | FLT3 | 0.53561366 |
| 81 | MAPK4 | 0.52347114 |
| 82 | CAMKK1 | 0.52058353 |
| 83 | NEK2 | 0.51602095 |
| 84 | MAPK12 | 0.49487514 |
| 85 | RPS6KC1 | 0.48864826 |
| 86 | RPS6KL1 | 0.48864826 |
| 87 | DAPK1 | 0.48322254 |
| 88 | TESK2 | 0.47360678 |
| 89 | CAMKK2 | 0.46010092 |
| 90 | FGR | 0.45361767 |
| 91 | PIK3CG | 0.44477149 |
| 92 | PRKD2 | 0.43516991 |
| 93 | TRPM7 | 0.43383311 |
| 94 | DYRK1B | 0.41987211 |
| 95 | FYN | 0.41638361 |
| 96 | MAP3K9 | 0.40921767 |
| 97 | MAPK7 | 0.40533489 |
| 98 | STK11 | 0.39894075 |
| 99 | MAP3K5 | 0.39324876 |
| 100 | RET | 0.39130142 |
| 101 | DMPK | 0.38760863 |
| 102 | STK4 | 0.38551839 |
| 103 | CDK19 | 0.38413714 |
| 104 | STK38 | 0.37383217 |
| 105 | PTK2B | 0.37354125 |
| 106 | PDPK1 | 0.37114007 |
| 107 | CDK9 | 0.36397277 |
| 108 | KSR2 | 0.35763869 |
| 109 | DAPK2 | 0.35513988 |
| 110 | CDK6 | 0.35412963 |
| 111 | MAP2K6 | 0.35168206 |
| 112 | MAP3K2 | 0.35012406 |
| 113 | GRK7 | 0.34984469 |
| 114 | RPS6KA6 | 0.34635082 |
| 115 | PDGFRB | 0.33694794 |
| 116 | BRD4 | 0.33686134 |
| 117 | RIPK1 | 0.31492910 |
| 118 | EPHA3 | 0.31112096 |
| 119 | EGFR | 0.31019980 |
| 120 | RAF1 | 0.29854578 |
| 121 | MAPKAPK2 | 0.29026654 |
| 122 | ABL1 | 0.27772255 |
| 123 | CAMK4 | 0.27375092 |
| 124 | MAP3K8 | 0.27135353 |
| 125 | MAPK11 | 0.26680378 |
| 126 | SCYL2 | 0.26633130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.74670600 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.95265414 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.50442687 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.47366656 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46501229 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.42049548 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19415039 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10736658 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.07296725 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.02794915 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99433616 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89773875 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.84777669 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82125705 |
| 15 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.69414180 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57902170 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54264225 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53848569 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46963073 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42600601 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42489152 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40953470 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.40724627 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39435440 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38478933 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.34656889 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34563708 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33647608 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.32650357 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.32055255 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.30954338 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27249656 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24347189 |
| 34 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.23309899 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.22003488 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19040010 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17168931 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16459043 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15913526 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15629184 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.15141259 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12803226 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.07031566 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.06419764 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02171892 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02055609 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96664732 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.95212712 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 0.92518835 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91826557 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88236017 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.85179036 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83750078 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83563420 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82043175 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.80716688 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79069555 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.76044747 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75254424 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75062148 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.74838316 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74742576 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74389554 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73329905 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73191575 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.70825896 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69307906 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67075725 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66687123 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66465604 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66175163 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66046410 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65391425 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65311912 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64279909 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63165505 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62660206 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61538114 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60897330 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59873216 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58886707 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57746756 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57719608 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57632370 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57133392 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56802503 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56075754 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54989896 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54805008 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.54600455 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.54306871 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54306799 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53535409 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.52111757 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51705536 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51588056 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51016487 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50244104 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46680029 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46222245 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44411962 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43929520 |
| 103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43691476 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43219496 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42117958 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.42019904 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41863176 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40583480 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40132604 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39533596 |

